Making sorafenib irresistible: In vivo screening for mechanisms of therapy resistance in hepatocellular carcinoma hits on Mapk14.
about
Inhibition of the prolyl isomerase Pin1 enhances the ability of sorafenib to induce cell death and inhibit tumor growth in hepatocellular carcinoma.LincRNA-p21 activates endoplasmic reticulum stress and inhibits hepatocellular carcinomaClinical implications of basic research in hepatocellular carcinoma.
P2860
Making sorafenib irresistible: In vivo screening for mechanisms of therapy resistance in hepatocellular carcinoma hits on Mapk14.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Making sorafenib irresistible: ...... ular carcinoma hits on Mapk14.
@en
Making sorafenib irresistible: ...... ular carcinoma hits on Mapk14.
@nl
type
label
Making sorafenib irresistible: ...... ular carcinoma hits on Mapk14.
@en
Making sorafenib irresistible: ...... ular carcinoma hits on Mapk14.
@nl
prefLabel
Making sorafenib irresistible: ...... ular carcinoma hits on Mapk14.
@en
Making sorafenib irresistible: ...... ular carcinoma hits on Mapk14.
@nl
P2860
P356
P1433
P1476
Making sorafenib irresistible: ...... lular carcinoma hits on Mapk14
@en
P2093
Matias Avila
P2860
P304
P356
10.1002/HEP.27739
P407
P577
2015-03-20T00:00:00Z